Doximity (DOCS) Gains from Investment Securities (2023 - 2024)

Doximity's (DOCS) quarterly Gains from Investment Securities came in at $202000.0 in Q2 2024, down 24.91% year-on-year from $269000.0 in Q3 2023, and up 10.38% on a QoQ basis from $183000.0 in Q1 2024.

Doximity (DOCS) Gains from Investment Securities (2023 - 2024) Analysis & Trends

Doximity (DOCS) has 2 years of Gains from Investment Securities data on file, last reported at $202000.0 in Q2 2024.

  • On a quarterly basis, Gains from Investment Securities fell 24.91% year-over-year to $202000.0 in Q2 2024; TTM through Jun 2024 was $1.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $951000.0, up 30.63% from the prior year.
  • Gains from Investment Securities for Q2 2024 stood at $202000.0, up from $183000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for DOCS reached as high as $405000.0 in Q1 2023 and fell as low as $183000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.81 Bn 24.50 Bn 662.02 Mn
2 BrightSpring Health Services 14.59 Bn 13.69 Bn 482.22 Mn
3 Healthequity 8.32 Bn 8.05 Bn 256.31 Mn
4 Hinge Health 5.97 Bn 5.65 Bn 154.23 Mn
5 10x Genomics 5.78 Bn 5.24 Bn 106.18 Mn
6 MiniMed 4.53 Bn 4.23 Bn 480.00 Mn
7 Waystar Holding 4.49 Bn 4.42 Bn 216.84 Mn
8 Doximity 3.99 Bn 3.24 Bn 125.97 Mn
9 Privia Health 3.18 Bn 2.76 Bn -
10 Omnicell 1.86 Bn 1.62 Bn 140.36 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 202,000.00
Jun 30, 2024 202,000.00
Mar 31, 2024 183,000.00
Mar 31, 2024 183,000.00
Jun 30, 2023 269,000.00
Jun 30, 2023 269,000.00
Mar 31, 2023 405,000.00
Mar 31, 2023 405,000.00